Dashboard
Weak Long Term Fundamental Strength with a -2.83% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.67 times
Flat results in Sep 25
With ROCE of 5.7, it has a Very Expensive valuation with a 0.6 Enterprise value to Capital Employed
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commercial Services & Supplies
INR 17 Cr (Micro Cap)
16.00
40
4.95%
0.41
2.53%
0.39
Total Returns (Price + Dividend) 
Latest dividend: 0.10000000000000002 per share ex-dividend date: Sep-23-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Zodiac Ventures Faces Intense Selling Pressure Amid Consecutive Losses
Zodiac Ventures Ltd has encountered significant selling pressure on 4 December 2025, with the stock registering a sharp decline of 4.72% in a single day and exhibiting a complete absence of buyers. This distress selling signals a challenging phase for the company within the Commercial Services & Supplies sector, as the stock continues to underperform against broader market indices and sector benchmarks.
Read More
Zodiac Ventures Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit
Zodiac Ventures Ltd has witnessed extraordinary buying momentum, registering a 4.61% gain today with only buy orders in the queue, signalling a potential multi-day upper circuit scenario. This surge stands in stark contrast to the broader market, as the Sensex declined by 0.34% over the same period, highlighting the stock’s distinct market activity within the Commercial Services & Supplies sector.
Read More
Zodiac Ventures Surges with Unprecedented Buying Interest, Potential Multi-Day Upper Circuit
Zodiac Ventures has witnessed extraordinary buying momentum today, registering a 4.83% gain with only buy orders in the queue, signalling a rare market phenomenon that could extend over multiple sessions. This surge stands in stark contrast to the broader market, as the Sensex declined by 0.25% during the same period.
Read More Announcements 
Unaudited Financial Results For The Quarter And Half-Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEUnaudited Financial Results for the quarter and half-year ended 30th September 2025.
Statement Of Deviation And Variation Under Regulation 32 Of The SEBI (LODR) Regulations 2015 For The Quarter Ended 30Th September 2025
14-Nov-2025 | Source : BSEWe hereby confirm that there was no deviation or variation in the use of proceeds of funds raised through Rights Issue of equity shares.
Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th November 2025
14-Nov-2025 | Source : BSEOutcome of the Board Meeting dated 14th November 2025.
Corporate Actions 
No Upcoming Board Meetings
Zodiac Ventures Ltd has declared 10% dividend, ex-date: 23 Sep 25
Zodiac Ventures Ltd has announced 1:10 stock split, ex-date: 21 Aug 14
No Bonus history available
Zodiac Ventures Ltd has announced 6:5 rights issue, ex-date: 18 Jul 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Ramesh Virji Shah (15.23%)
Nilesh Kantilal Jobanputra (5.8%)
62.1%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 3.13% vs 113.33% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -3.33% vs 11.11% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 120.34% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 63.89% vs -36.84% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 113.11% vs 1,120.00% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -6.45% vs 181.82% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 171.19% vs -99.40% in Mar 2024
YoY Growth in year ended Mar 2025 is 98.04% vs -75.24% in Mar 2024






